Clinical trial
The APPROVE Trial: A Randomized Controlled Trial Evaluating the Efficacy and Safety of a Prescription Digital Therapeutic for Treatment of Overactive Bladder in Women
NCT06797245 is registered in ClinicalTrials.gov with Medstar Health Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The APPROVE Trial: A Randomized Controlled Trial Evaluating the Efficacy and Safety of a Prescription Digital Therapeutic for Treatment of Overactive Bladder in Women
- Lead sponsor
- Medstar Health Research Institute
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- March 17, 2025
- Completion date
- July 31, 2028
- Enrollment
- 596 (estimated)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.
nocturia, overactive bladder (oab), urinary frequency, urinary urge incontinence (uui), urinary urgency